GPX3 and B-cell chronic lymphocytic leukemia: In the CLL cybrid, there were reduced GPX3 levels in response to Ibr + ALA (0.4-fold change, p < 0.0001), Ibr + Mel (0.2-fold change, p < 0.001), and Ibr + Resv (0.3-fold change, p < 0.001).